STUDY QUESTION: What are the underlying mechanisms of the decline in the fertilization ability of post-ovulatory aged oocytes?
Introduction
Ovulated mouse oocytes are surrounded by an extracellular zona pellucida composed of ZP1, ZP2 and ZP3. For successful fertilization, a single capacitated sperm binds to the N-terminal domain of ZP2, penetrates the zona matrix and binds to the oocyte via interactions between Izumo1 on the sperm head and Juno on the oocyte membrane. Fusion of the oocyte with a second sperm results in polyspermy and this is protected against by postfertilization modifications of both the zona matrix and the oocyte plasma membrane. Dysregulation of these protective measures results in loss of reproductive fitness.
The postfertilization modification of the zona pellucida is mediated by cortical granule (CG) exocytosis. CGs are subcellular organelles unique to oocytes that originate from the Golgi apparatus at the onset of follicular growth and migrate to the cortex to form a continuous layer under the oolemma (Zamboni, 1970; Ducibella et al., 1994; Hoodbhoy and Talbot, 1994; Liu et al., 2005) . In mammals, CG distribution is polarized because of exclusion from an actin cap which forms a CG-free domain (CGFD) overlying the second meiotic spindle (Szollosi, 1967; Nicosia et al., 1977; Longo and Chen, 1985; Okada et al., 1986) . After fertilization, the CGs fuse with the oocyte plasma membrane and exocytose their contents into the extracellular space. A mammalian component of CGs is ovastacin, an oocyte-specific metalloendoprotease that cleaves ZP2 ( ) after fertilization (Quesada et al., 2004; Burkart et al., 2012) . Genetic mutation of the ZP2 cleavage site or ablation of ovastacin leaves ZP2 unmodified which supports sperm binding to the zona pellucida despite fertilization and CG exocytosis (Gahlay et al., 2010; Burkart et al., 2012) .
After successful navigation of the zona pellucida, only acrosomereacted sperm are present in the perivitelline space and available for fusion with the oocyte. Izumo1 on the surface of sperm head interacts with Juno (formerly Folr4) in the oocyte membrane to promote gamete fusion (Inoue et al., 2005; Bianchi et al., 2014; Grayson, 2015) . Juno is a glycophosphatidylinositol-anchored protein that is uniquely present in oocytes and rapidly disappears following fertilization (Bianchi et al., 2014) . Genetic ablation of either Izumo1 or Juno prevents gamete fusion and leads to gender-specific infertility (Inoue et al., 2005; Bianchi et al., 2014) .
In mammals, timely fertilization of oocytes following ovulation is crucial for successful reproduction (Lord et al., 2015) . However, many mammalian species restrict sexual activity to distinct estrous periods and ovulation and fertilization may not be synchronized (Tarin et al., 2002) . With increasing time following ovulation, oocytes deteriorate in vivo and in vitro in a process known as post-ovulatory aging (Tarin et al., 1999; Zhang et al., 2016) . Numerous studies have shown that post-ovulatory aging of mammalian oocytes in vitro is inherently linked with oxidative stress , a result of the imbalance between the production and consumption of reactive oxygen species (ROS) (Tamura et al., 2008; Galano et al., 2011) .
ROS can damage the cell membrane and induce the apoptosis, which thereby harms the fertilization potential of oocytes by perturbing fertilization-related regulators and events (Zhao et al., 2016) . Melatonin (N-acetyl-5-methoxytrypt amine) is a major pineal secretory product (Gao et al., 2012) that mediates circadian rhythms and regulates seasonal reproductive activity (Lincoln et al., 2006) . Melatonin is especially effective as an antioxidant because it exhibits a wide variety of means to reduce oxidative stress (Garcia et al., 2014; Manchester et al., 2015; Reiter et al., 2016) , and its metabolites are potent free radical scavengers and antioxidants (Chen et al., 2006; Manda et al., 2007; Bonnefont-Rousselot et al., 2011; Galano et al., 2011; Zhang and Zhang, 2014) . Recent studies have shown that supplementation of melatonin during oocyte culture increases the rate of fertilization and promotes early embryonic development in mice (Ishizuka et al., 2000; Wang et al., 2013) . However, the underlying mechanisms regarding how melatonin improves the quality and fertilization potential of the post-ovulatory aged oocytes are still not fully defined. We now report that post-ovulatory aging compromises the fertilization ability of mouse oocytes by inducing precocious exocytosis of ovastacin that causes premature cleavage of the sperm binding domain of ZP2 and loss of sperm binding to the zona pellucida. Post-ovulatory aging also disrupts the abundance of Juno, the sperm receptor on the oocyte membrane, which affects gamete fusion. These post-ovulatory aging defects appear in line with the generation of ROS and can be ameliorated by media supplementation with melatonin.
Materials and Methods

Animals and feeding
All mice were handled in accordance with the Animal Research Institute Committee guidelines of Nanjing Agricultural University, China. The female 4-week-old ICR (Institute of Cancer Research) mice were kept under controlled conditions with a constant temperature (20-23°C) and a 12-h light/dark cycle, and had free access to food and water throughout the period of the study.
In-vitro fertilization
Cauda epididymides were lanced in a dish of human tubal fluid (HTF) medium (EMD Millipore, Billerica, MA, USA) to release sperm that were capacitated for 1 h (37°C, 5% CO 2 ) and added to ovulated oocytes at a concentration of 4×10 5 /ml sperm in 100 μl HTF for 5 h at 37°C, 5% CO 2 .
The presence of two pronuclei was scored as successful fertilization.
Sperm binding assay
Caudal epididymal sperm were isolated from 12-week-old ICR male mice and placed under oil (Sigma-Aldrich, MO, USA) in HTF medium previously equilibrated with 5% CO 2 and capacitated by an additional 1 h of incubation at 37°C. Sperm binding to control, aged and melatonin-treated aged oocytes or two-cell embryos was observed using capacitated sperm and control two-cell embryos as a negative wash control. Samples were fixed in 4% PFA for 30 min and stained with Hoechst 33342. Bound sperm were quantified from z projections acquired by confocal microscopy, and the results reflect the mean ± SEM from at least three independently obtained samples, each containing 10-12 mouse oocytes or embryos.
Immunofluorescence and confocal microscopy
Mouse oocytes were fixed in 4% paraformaldehyde in PBS (pH 7.4) for 30 min and permeabilized in 0.5% Triton-X-100 for 20 min at room temperature. Then, oocytes were blocked with 1% BSA (bovine serum albumin)-supplemented PBS for 1 h and incubated at 4°C overnight or at room Figure 2 Effect of melatonin on sperm binding to the zona pellucida of post-ovulatory aged oocytes. (A) Oocytes and two-cell embryos from control and aged groups were incubated with capacitated sperm for 1 h. After washing with a wide-bore pipette, which removes all but two to six sperm on normal two-cell embryos (negative control), oocytes and embryos with sperm were fixed and stained with Hoechst 33342. Scale bar, 20 μm.
The number of sperm binding to the surface of zona pellucida surrounding oocytes from control, aged and melatonin-supplemented groups. Data are presented as mean percentage (mean ± SEM) of at least three independent experiments. Asterisk denotes statistical difference at a P < 0.05.
temperature for 4 h with rat monoclonal anti-mouse Folr4-FITC antibody (1:100, BioLegend, CA, USA) or rabbit polyclonal anti-mouse ovastacin antibody (1:100, obtained from Dr Jurrien Dean). After washing four times (5 min each) in PBS containing 1% Tween 20 and 0.01% Triton-X 100, oocytes were incubated with an appropriate secondary antibody for 1 h at room temperature. Alexa Fluor 488 donkey anti-rabbit IgG (H+L) was obtained from Invitrogen (Carlsbad, CA, USA). After washing three times, oocytes were counterstained with Hoechst 33342 (10 µg/ml) for 10 min. Finally, oocytes were mounted on glass slides and viewed under a confocal laser scanning microscope (Carl Zeiss LSM 700 META).
Western blot analysis
For ZP2 cleavage experiments, 12 mouse oocytes or two-cell embryos were lysed in 4× LDS sample buffer with 10× reducing reagent (Life Technologies) and heated at 95°C for 5 min. For Juno and ovastacin detection, 400 mouse oocytes were lysed in 4× LDS sample buffer and heated at 95°C for 5 min. Proteins were separated on 12% Bis-Tris precast gels, transferred to PVDF membranes, blocked in 5% nonfat milk in TBS (Tris buffered saline, pH 7.4) with 0.1% Tween 20 (TBST) for 1 h at room temperature, and then probed with 1:500 dilution of M2c.2 antibody (obtained from Dr Jurrien Dean), rat monoclonal anti-mouse Folr4 antibody (1:1000, BioLegend, CA, USA) or rabbit polyclonal anti-mouse ovastacin antibody (1:1000) at 4°C overnight. After washing three times in TBST (10 min each), blots were incubated for 1 h with a 1:5000 dilution of Horse Radish Peroxidase conjugated goat anti-rat or goat anti-rabbit IgG secondary antibodies (Santa Cruz, TX, USA). Chemiluminescence was performed with ECL Plus (Piercenet) and signals were acquired by Tanon-3900.
Determination of ROS generation
To determine the levels of intracellular ROS production, cumulus-denuded mouse oocytes were incubated with the oxidation-sensitive fluorescent probe [dichlorofluorescein (DCFH)] for 30 min at 37°C in DPBS (Dulbecco's Phosphate Buffered Saline) that contained 10 μM DCFH diacetate (DCFHDA) (Beyotime Institute of Biotechnology, China). Oocytes were then washed three times in DPBS containing 0.1% BSA and placed on glass slides. The fluorescent intensity in each oocyte was measured by Zeiss LSM 700 META confocal system with the same scanning settings.
Annexin-V staining
As per the manufacturer's instruction (Beyotime Institute of Biotechnology, Hangzhou, China), mouse oocytes were stained with the Annexin-V staining kit. After washing twice in PBS, the viable oocytes were stained for 30 min in the dark with 90 µl of binding buffer containing 10 µl of Annexin-V-FITC. Fluorescent signals were measured by the confocal microscope with the same scanning settings (Zeiss LSM 700 META).
Statistical analysis
The data from at least three repeated experiments were expressed as mean ± SEM and analyzed by one-way ANOVA, followed by LSD's post hoc test, which was provided by SPSS16.0 statistical software. The level of significance was accepted as P < 0.05.
Results
Melatonin improves the fertilization potential of post-ovulatory aged mouse oocytes
To examine whether post-ovulatory aging impairs fertilization, we compared in-vitro fertilization rates of mouse oocytes aged in vitro for 0, 6, 12 and 24 h. Most control oocytes could be fertilized and could develop to two-cell embryos, while aged oocytes had varying degrees of reduced fertilization ability (Fig. 1A, B) . Oocytes aged for 24 h had significantly lower fertilization rate compared to controls (88.6 ± 2.9%, n = 110 vs. 35.6 ± 2.2%, n = 83) and this time point was chosen for subsequent investigations (Fig. 1B) . To determine the effect of melatonin on the fertilization of aged oocytes, we cultured oocytes for 24 h with increasing concentrations of melatonin (10 −9 M, 10 −7 M, 10 −5 M and 10 −3 M) and then performed in-vitro fertilization. As expected, the rate of fertilization increased in the melatonin-treated aged oocytes and supplementation with 10 −3 M melatonin significantly increased the fertilization rate compared to control aged oocytes to 64.2 ± 1.3% (n = 92) from 43.7 ± 2.5% (n = 87) (Fig. 1C) . Due to limited solubility, 10 −3 M was the maximum concentration that we tested and this was used for subsequent investigations. Collectively, these results indicate that melatonin can improve the fertilization ability of aged mouse oocytes.
Melatonin elevates the sperm binding ability of post-ovulatory aged oocytes
To determine the number of sperm binding to the extracellular zona pellucida, gamete nuclei were stained with Hoechst and imaged by confocal microscopy. The zona pellucida surrounding control, unfertilized oocytes robustly supported sperm binding and the postfertilization cleavage of ZP2 prevented sperm binding to the zona matrix surrounding two-cell embryos. However, in aged oocytes, the number of sperm binding to the zona pellucida was substantially reduced compared with the control oocytes (58.3 ± 9.0, n = 42 vs. 11.5 ± 0.7, n = 35) ( Fig. 2A, B ). In contrast, after treatment with melatonin, the number of sperm binding to unfertilized aged oocytes was significantly increased compared with untreated aged oocytes (11.5 ± 0.7, n = 35 vs. 30.0 ± 0.6, n = 33) ( Fig. 2A, B) . Taken together, these results indicate that melatonin can restore the ability of sperm to bind to aged oocytes.
Melatonin reduces ZP2 cleavage in post-ovulatory aged oocytes
Sperm binding to zona pellucida is determined by the cleavage status of N-terminus of ZP2, independent of fertilization and CG exocytosis (Gahlay et al., 2010) . Using M2c.2 antibody which has been previously used to detect the cleavage of ZP2 by western blot (Gahlay et al., 2010; Burkart et al., 2012) , we observed that ZP2 was intact (120 kD) in unfertilized oocytes and cleaved (90 kD) in two-cell embryos (Fig. 3A) . Unexpectedly, partially cleaved ZP2 was observed in unfertilized oocytes in the aged group (Fig. 3A, B) suggesting that aged oocytes lose ZP2 sperm binding sites. These observations are consistent with the above sperm binding assay in which fewer sperm bound to the zona pellucida surrounding aged oocytes. Since melatonin can partially restore the sperm binding of aged oocytes, we investigated the cleavage status of ZP2 in the zona pellucida in the presence of melatonin. As expected, although ZP2 was also partially cleaved in the melatonin-supplemented aged group, the cleavage level was lower compared to that in the aged oocytes (Fig. 3A, B) .
Melatonin rescues the localization and abundance of ovastacin in post-ovulatory aged oocytes
To further investigate the inability of sperm to bind the zona pellucida of aged oocytes, we determined the localization and protein level of ovastacin, an oocyte, CG-specific metalloprotease responsible for the postfertilization cleavage of ZP2. Immunofluorescent analysis detected ovastacin in the subcortex of ovulated control oocytes with exclusion from the CGFD. In striking contrast, ovastacin was abnormally located in aged oocytes and these spatial anomalies could be rescued by treatment with melatonin (Fig. 4A) . The frequency of abnormally located ovastacin in aged oocytes was significantly higher than that in controls (85.4 ± 1.5%, n = 98 vs. 18.1 ± 3.6%, n = 87) and was markedly reduced by treatment with melatonin (85.4 ± 1.5%, n = 98 vs. 50.0 ± 8.1%, n = 90) (Fig. 4B ). In addition, the abundance of ovastacin protein was substantially decreased in aged oocytes (Fig. 4C ), suggesting that a portion of ovastacin had been prematurely exocytosed which could account for the partial cleavage of ZP2 in the extracellular zona matrix. However, treatment with melatonin partially restored the protein levels of ovastacin (Fig. 4C) . Collectively, these data indicate that post-ovulatory aging of oocytes results in the mislocalization and premature exocytosis of ovastacin which leads to defects in sperm binding and failed fertilization.
Melatonin restores formation of the actin cap in post-ovulatory aged oocytes
During meiotic maturation, chromosomes move to the oocyte cortex and stimulate formation of a CGFD in which actin polymerizes to form an actin cap. The biological significance of the CGFD is not fully clear, but it is thought that sperm are less likely to fuse at this region to protect the maternal genetic material. Based on the above observation that ovastacin in the CGs is mislocalized in aged oocytes, we hypothesized that formation of the actin cap also would be impaired during aging process. In control oocytes, the actin caps formed normally in the CGFD region with few exceptions (Fig. 5A) . However, in aged oocytes, the rate of aberrant actin cap formation was increased compared to control oocytes (53.5 ± 4.7%, n = 69 vs. 14.8 ± 3.1%, n = 73), but could be reduced by treatment with melatonin (27.2 ± 7.1%, n = 77 vs. 53.5 ± 4.7%, n = 69) (Fig. 5B ).
Melatonin restores Juno in the membrane of post-ovulatory aged oocytes
After sperm bind and penetrate the zona pellucida, they fuse with the oocyte membrane via Juno's interaction with Izumo1, a sperm surface receptor. In control oocytes, Juno was evenly distributed on the oocyte membranes, but it was partly or entirely absent in aged oocytes (Fig. 6A ). Based on immunofluorescent intensity, the abundance of Juno was significantly decreased in aged oocytes compared to control oocytes (16.6 ± 1.7, n = 78 vs. 41.1 ± 2.7, n = 69) (Fig. 6B) . Incubation with melatonin during aging partially restored the Juno signal on the oocyte membrane (24.2 ± 2.0, n = 72 vs. 16.6 ± 1.7, n = 78) (Fig. 6B) which was confirmed by western blot (Fig. 6C) . We conclude that the reduced abundance of Juno in the oocyte membrane is likely to play an important role in the decreased fertilization ability of aged mouse oocytes.
Melatonin decreases ROS and suppresses early apoptosis in post-ovulatory aged oocytes
We hypothesized that aging induces oxidative stress which accelerates apoptosis and leads to degradation of ovastacin and Juno which are critical regulators of fertilization. To investigate potential antioxidant effects of melatonin, we assessed ROS levels and apoptosis. In aged oocytes, the fluorescent intensity of ROS was increased compared to controls (153.6 ± 10.8, n = 45 vs. 78.8 ± 5.1, n = 40) and supplementation with melatonin during aging reduced ROS levels (153.6 ± 10.8, n = 45 vs. 97.8 ± 5.9, n = 50) (Fig. 7A, B) . We also investigated apoptosis by staining for Annexin-V to detect the translocation of phosphatidylserine from the inner to the outer leaflet of the cell membrane. The green fluorescent signal was detected faintly in control oocytes, but clearly observed on the membrane of aged oocytes (Fig. 7C) . The proportion of apoptotic oocytes was dramatically higher in aged group than in controls (74.3 ± 0.7%, n = 34 vs. 30.3 ± 3.0%, n = 35) but was rescued in melatonin-supplemented group (74.3 ± 0.7%, n = 34 vs. 54.9 ± 1.6%, n = 30) (Fig. 7D) . Collectively, these results provide a body of evidence documenting that melatonin improves the fertilization potential of post-ovulatory aged oocytes by maintaining the localization and protein level of two critical fertilization participants, ovastacin and Juno, and by reducing aging-induced ROS levels and by inhibiting apoptosis (Fig. 8) .
Discussion
The application of melatonin in human clinics to improve success rates of IVF traces a long historic road of scientific discovery. Melatonin, now known to be a robust antioxidant (Reiter et al., 2016) , was first reported in human preovulatory follicular fluid almost 30 years ago (Brzezinski et al., 1987) and was subsequently shown to increase IVF rates and early embryo development in mice (Ishizuka et al., 2000) and to increase IVF rates in humans (Tamura et al., 2008) . More recently, melatonin has been found to prevent post-ovulatory oocyte aging and extend the window for optimal fertilization in mice . However, the underlying molecular basis for these observations has remained unknown.
Recent advances based on molecular cell biology and mouse genetics have proposed a model of gamete recognition in which capacitated sperm bind to the N-terminus of ZP2 in the extracellular zona pellucida, penetrate through the zona matrix and fuse to Juno in the oocyte membrane to effect fertilization (Gahlay et al., 2010; Baibakov et al., 2012; Avella et al., 2014; Bianchi et al., 2014) . After fertilization, Juno is lost from the oocyte plasma membrane (Bianchi et al., 2014) and exocytosis of ovastacin from CGs modifies ZP2 so that sperm cannot bind to the zona pellucida (Burkart et al., 2012) .
In our current results, we document that post-ovulatory aging dramatically reduced the number of sperm binding to the zona pellucida concomitant with mislocalized CGs. The subsequent partial cleavage of ZP2 most likely results from premature exocytosis of ovastacin and is the hallmark of the zona hardening reaction (Burkart et al., 2012) , which effectively blocks sperm binding to the surface of the zona matrix. In addition, we observed a decrease in the abundance of Juno on the membrane of aged oocytes which would prevent interactions with Izumo1 on the sperm surface and decreased rates of fertilization.
Most importantly, we found that the defects caused by the postovulatory aging could be restored, at least partially, by supplementation with melatonin during the aging process in vitro. It has been shown by us and others that post-ovulatory aged oocytes suffer from oxidative stress with increased level of ROS which induces apoptosis. The deleterious effect on the developmental potential of oocytes adversely affects fertilization rates (Simon et al., 2000; Gao et al., 2012; Zhao et al., 2016) .
Taken together, our findings provide a clinical implication in that supplementation with melatonin has the potential to prolong in vitro culture periods of retrieved oocytes for IVF cycle and elevate the IVF rate in human ART. Although re-insemination of aged unfertilized oocytes failing in IVF cycles could be achieved with ICSI via bypassing impaired sperm binding and fusion, the deteriorated oocyte quality would impede the subsequent development potential. Figure 8 Working model of melatonin-mediated improvement of fertilization in post-ovulatory aged mouse oocytes. Post-ovulatory aging induces high level of ROS and early apoptosis which may damage two critical regulators of fertilization, ovastacin and Juno. Consequently, premature exocytosis of ovastacin causes the cleavage of ZP2 and decreased sperm binding ability to the zona pellucida. The concomitant loss of Juno on the oocyte membrane compromised gamete fusion, and combined, these two defects result in decrease fertilization rates of post-ovulatory aged oocytes. Melatonin restores the fertilization ability possibly by inhibiting the ROS and apoptosis and maintaining the functions of ovastacin and Juno. Dash lines denote that post-ovulatory aging might disrupt ovastacin and Juno via additional, yet to be described, mechanisms.
